1979
Mucha-Habermann's disease
Search citation statements
Paper Sections
Select...
6
4
0
0
Citation Types
0
9
0
0
Year Published
1996
2024
Publication Types
Select...
10
Relationship
0
10
Authors
Journals
Cited by 10 publications
(9 citation statements)
References 0 publications
0
9
0
0
“…For instance, Truhan et al. 9 reported an 87% response rate in their 15 patients with PL whereas in another study there was consistently no beneficial response noted 10 . Gelmetti et al.…”
Section: Discussionmentioning
confidence: 95%
“…For instance, Truhan et al. 9 reported an 87% response rate in their 15 patients with PL whereas in another study there was consistently no beneficial response noted 10 . Gelmetti et al.…”
Section: Discussionmentioning
confidence: 95%
“…For instance, Truhan et al 9 reported an 87% response rate in their 15 patients with PL whereas in another study there was consistently no beneficial response noted. 10 Gelmetti et al found erythromycin only 'moderately effective'. 7 Ersoy-Evans et al 5 reported 61% of children cleared completely following treatment with erythromycin.…”
Section: Discussionmentioning
confidence: 99%
“…There have been only a few reports regarding the treatment of children with PL with oral antibiotics including erythromycin (26,27). Shavin et al (26) described three children with PLEVA successfully treated with erythromycin.…”
Section: Discussionmentioning
confidence: 99%
“…Shavin et al (26) described three children with PLEVA successfully treated with erythromycin. Rasmussen et al (27) reported no response in eight children treated with erythromycin in PLEVA. Later, in another study (12) that included 15 children with PLEVA, 11 (73%) achieved remission within 2 months of the initiation of therapy.…”
Section: Discussionmentioning
confidence: 99%
“…An 18‐year‐old adolescent with febrile ulceronecrotic PLEVA was treated with PUVA and methotrexate with a beneficial response (15). Four adolescents with severe progressive PLEVA unresponsive to erythromycin, tetracycline, and prednisolone responded to methotrexate 2.5 mg given every 12 hours for three doses (16). Despite oral erythromycin and topical steroids for 2 weeks prior to admission, our patient with febrile ulceronecrotic PLEVA continued to worsen rapidly.…”
Section: Discussionmentioning
confidence: 99%
